# Stress-induced epigenome changes as a risk factor in the onset of mental disorders

**Authors:** Liliia Shkarina, Kirill Bozov, Stalik Dzhauari, Alexandra Primak, Vsevolod Tkachuk, Yuliya Chaika, Elena Neyfeld, Maxim Karagyaur

PMC · DOI: 10.3389/fpsyt.2026.1764368 · Frontiers in Psychiatry · 2026-02-11

## TL;DR

Stress can cause epigenetic changes that increase the risk of mental disorders like depression and anxiety, especially during critical brain development stages.

## Contribution

This review summarizes how stress affects epigenetic modifiers and gene expression, offering insights into new diagnostic and therapeutic approaches for mental disorders.

## Key findings

- Stress-induced epigenetic changes may explain the rising prevalence of mental disorders.
- Chronic stress impacts brain development and function through altered gene expression.
- Stress effects are most significant during prenatal and early postnatal stages.

## Abstract

The global mental health study has revealed a steady increase in the prevalence of mental disorders worldwide. This trend reflects not only the improvements in diagnostics but also the global population ageing and the intensification of negative environmental impacts that provoke the manifestation of such disorders. One of such primary external causes for mental disorders is stress, which accompanies humans throughout their lives. Stressful exposure, particularly chronic stress, can alter the expression of genes involved in the development, maturation, and functioning of the nervous system, which in turn may provoke the manifestation of mental disorders in susceptible individuals. The effects of stress can explain the increasing prevalence of mental illnesses (depression, anxiety disorders), and their aggravation with age. Stress seems to have the greatest impact during critical periods of brain development: intrauterine and early postnatal stages. The molecular mechanisms mediating the impact of stress on the expression of genes crucial for brain development and function, as well as the list of genes involved, remain poorly understood. In this review, we have attempted to summarize the known information on the influence of stress on the activity of epigenetic modifiers and the state of the epigenome, the expression of target genes, brain development, and changes in behavioral patterns. Studying such mechanisms and the genes involved opens up opportunities for diagnosing mental disorders at a new methodological level and potentially offers new precision approaches to their therapeutic correction at the epigenomic level.

## Linked entities

- **Diseases:** depression (MONDO:0002050)

## Full-text entities

- **Genes:** SIN3A (SIN3 transcription regulator family member A) [NCBI Gene 25942] {aka CHR15DELq24, DEL15Q24, WITKOS}, TPPP (tubulin polymerization promoting protein) [NCBI Gene 11076] {aka TPPP/p25, TPPP1, p24, p25, p25alpha}, PM20D1 (peptidase M20 domain containing 1) [NCBI Gene 148811] {aka Cps1}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, RING1 (ring finger protein 1) [NCBI Gene 6015] {aka RING1A, RNF1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, NOS1 (nitric oxide synthase 1) [NCBI Gene 4842] {aka IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS}, GRIN1 (glutamate ionotropic receptor NMDA type subunit 1) [NCBI Gene 2902] {aka DEE101, GluN1, MRD8, NDHMSD, NDHMSR, NMD-R1}, CPA1 (carboxypeptidase A1) [NCBI Gene 1357] {aka CPA}, SLC6A4 (solute carrier family 6 member 4) [NCBI Gene 6532] {aka 5-HTT, 5-HTTLPR, 5HTT, HTT, OCD1, SERT}, Mecp2 (methyl CpG binding protein 2) [NCBI Gene 17257] {aka 1500041B07Rik, D630021H01Rik, Mbd5, WBP10}, OLFM3 (olfactomedin 3) [NCBI Gene 118427] {aka NOE3, NOELIN3, OPTIMEDIN}, EP300 (EP300 lysine acetyltransferase) [NCBI Gene 2033] {aka KAT3B, MKHK2, RSTS2, p300}, Camk2g (calcium/calmodulin-dependent protein kinase II gamma) [NCBI Gene 12325] {aka Camkg}, CRHBP (corticotropin releasing hormone binding protein) [NCBI Gene 1393] {aka CRF-BP, CRFBP}, RELN (reelin) [NCBI Gene 5649] {aka ETL7, LIS2, PRO1598, RL}, RPS6KA5 (ribosomal protein S6 kinase A5) [NCBI Gene 9252] {aka MSK1, MSPK1, RLPK}, NGF (nerve growth factor) [NCBI Gene 4803] {aka Beta-NGF, HSAN5, NGFB}, CAMKMT (calmodulin-lysine N-methyltransferase) [NCBI Gene 79823] {aka C2orf34, CLNMT, CaM KMT, Cam, KMT}, HSPG2 (heparan sulfate proteoglycan 2) [NCBI Gene 3339] {aka HSPG, PLC, PRCAN, SJA, SJS, SJS1}, Nr3c1 (nuclear receptor subfamily 3, group C, member 1) [NCBI Gene 14815] {aka GR, Grl-1, Grl1}, JUND (JunD proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3727] {aka AP-1}, CAMK4 (calcium/calmodulin dependent protein kinase IV) [NCBI Gene 814] {aka CaMK IV, CaMK-GR, CaMKIV, caMK}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, DUSP22 (dual specificity phosphatase 22) [NCBI Gene 56940] {aka JKAP, JSP-1, JSP1, LMW-DSP2, LMWDSP2, MKP-x}, MECP2 (methyl-CpG binding protein 2) [NCBI Gene 4204] {aka AUTSX3, MRX16, MRX79, MRXS13, MRXSL, PPMX}, OXTR (oxytocin receptor) [NCBI Gene 5021] {aka OT-R, OTR}, COMT (catechol-O-methyltransferase) [NCBI Gene 1312] {aka HEL-S-98n}, NCOR1 (nuclear receptor corepressor 1) [NCBI Gene 9611] {aka N-CoR, N-CoR1, PPP1R109, TRAC1, hN-CoR}, KLHL35 (kelch like family member 35) [NCBI Gene 283212], ID3 (inhibitor of DNA binding 3) [NCBI Gene 3399] {aka HEIR-1, bHLHb25}, CBX5 (chromobox 5) [NCBI Gene 23468] {aka HEL25, HP1, HP1A, HP1alpha}, CRH (corticotropin releasing hormone) [NCBI Gene 1392] {aka CRF, CRH1}, NTRK2 (neurotrophic receptor tyrosine kinase 2) [NCBI Gene 4915] {aka DEE58, EIEE58, GP145-TrkB, OBHD, TRKB, trk-B}, ZNF714 (zinc finger protein 714) [NCBI Gene 148206], DKK1 (dickkopf Wnt signaling pathway inhibitor 1) [NCBI Gene 22943] {aka DKK-1, SK}, Hdac1 (histone deacetylase 1) [NCBI Gene 433759] {aka HD1, Hdac1-ps, MommeD5, RPD3}, RBFOX1 (RNA binding fox-1 homolog 1) [NCBI Gene 54715] {aka 2BP1, A2BP1, FOX-1, FOX1, HRNBP1}, NR3C1 (nuclear receptor subfamily 3 group C member 1) [NCBI Gene 2908] {aka GCCR, GCR, GCRST, GR, GRL}, PTEN (phosphatase and tensin homolog) [NCBI Gene 5728] {aka 10q23del, BZS, CWS1, DEC, GLM2, MHAM}, CHR [NCBI Gene 1125], Egr1 (early growth response 1) [NCBI Gene 24330] {aka Krox-24, NGFI-A, Ngf1, Ngfi, zif-268}, CHPT1 (choline phosphotransferase 1) [NCBI Gene 56994] {aka CPT, CPT1}, Bdnf (brain derived neurotrophic factor) [NCBI Gene 12064], PHF14 (PHD finger protein 14) [NCBI Gene 9678], DNMT3A (DNA methyltransferase 3 alpha) [NCBI Gene 1788] {aka DNMT3A2, HESJAS, M.HsaIIIA, TBRS}, MAOA (monoamine oxidase A) [NCBI Gene 4128] {aka BRNRS, MAO-A}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, TET3 (tet methylcytosine dioxygenase 3) [NCBI Gene 200424] {aka BEFAHRS, hCG_40738}, NTRK1 (neurotrophic receptor tyrosine kinase 1) [NCBI Gene 4914] {aka MTC, TRK, TRK1, TRKA, Trk-A, p140-TrkA}, PRC1 (protein regulator of cytokinesis 1) [NCBI Gene 9055] {aka ASE1, MAP65}, Sin3a (SIN3 transcription regulator family member A) [NCBI Gene 20466] {aka Sin3, mKIAA4126, mSin3A}, GDF7 (growth differentiation factor 7) [NCBI Gene 151449] {aka BMP12}, SLC1A4 (solute carrier family 1 member 4) [NCBI Gene 6509] {aka ASCT1, SATT, SPATCCM}, NCOR2 (nuclear receptor corepressor 2) [NCBI Gene 9612] {aka CTG26, N-CoR2, SMAP270, SMRT, SMRTE, SMRTE-tau}, Esr1 (estrogen receptor 1 (alpha)) [NCBI Gene 13982] {aka ER, ER-alpha, ERa, ERalpha, ESR, Estr}, HDAC3 (histone deacetylase 3) [NCBI Gene 8841] {aka HD3, KDAC3, RPD3, RPD3-2}, RCOR1 (REST corepressor 1) [NCBI Gene 23186] {aka COREST, RCOR}, HDAC9 (histone deacetylase 9) [NCBI Gene 9734] {aka HD7, HD7b, HD9, HDAC, HDAC7B, HDAC9B}, ELK1 (ETS transcription factor ELK1) [NCBI Gene 2002]
- **Diseases:** trauma (MESH:D014947), mental and neurodegenerative disorders (MESH:D019636), glucocorticoid resistance (MESH:C564221), ASD (MESH:D000067877), mental disorder (MESH:D001523), neurological and cognitive impairments (MESH:D060825), cancers (MESH:D009369), autism (MESH:D001321), anxiety (MESH:D001007), schizophrenia (MESH:D012559), affective disorders (MESH:D019964), HPA (MESH:D007029), Metabolic (MESH:D008659), MDD (MESH:D003865), PTSD (MESH:D013313), anxiety disorders (MESH:D001008), nutritional deficits (MESH:D009748), mental abnormalities (MESH:D008607), Rett syndrome (MESH:D015518), volume reduction (MESH:D015431), depression (MESH:D003866), bipolar (MESH:D001714), mental and cognitive diseases (MESH:D003072)
- **Chemicals:** corticosterone (MESH:D003345), cytosine (MESH:D003596), 5-methylcytosine (MESH:D044503), acetyl-CoA (MESH:D000105), S-adenosylmethionine (MESH:D012436), trichostatin A (MESH:C012589), glutamate (MESH:D018698), NO (MESH:D009569), cAMP (-), 5-hydroxymethylcytosine (MESH:C011865), 5-formylcytosine (MESH:C560973), Dexamethasone (MESH:D003907), 5-carboxylcytosine (MESH:C560974), steroid hormones (MESH:D013256), sodium butyrate (MESH:D020148), serotonin (MESH:D012701)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs1085308044, rs8084351, rs701848, rs7193263, rs6265, rs1360780
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12932522/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12932522/full.md

## References

165 references — full list in the complete paper: https://tomesphere.com/paper/PMC12932522/full.md

---
Source: https://tomesphere.com/paper/PMC12932522